Psychedelics vs Antidepressants: What a New Meta-Analysis Really Shows
The headline is hard to miss: “Psychedelics may be no better than antidepressants for depression,” as reported by New Scientist (Busby, 2026). For those following psychedelic research with hope (and for the field itself), it stings. But beneath the surface, the actual story is more complex than the headlines suggest. A meta-analysis published in JAMA […] The post Psychedelics vs Antidepressants: What a New Meta-Analysis Really Shows appeared first on OPEN Foundation.
External link. We are not responsible for the content.
Read more ↗More From OPEN Foundation
Truffles, therapy, disciplinary law – An OPEN perspective on the grey area in which (licensed) therapists operate in the Netherlands with regard to psychedelics
Read this article in Dutch here. On May 8, 2026, the Amsterdam Healthcare Disciplinary Board ruled on a significant c...
Truffels, therapie, tuchtrecht: Een OPEN perspectief op het grijze gebied waarin (BIG-geregistreerde) therapeuten opereren in Nederland met betrekking tot psychedelica
Op 8 mei 2026 deed het Regionaal Tuchtcollege voor de Gezondheidszorg Amsterdam uitspraak in een belangwekkende zaak,...
Science Revisits Kykeon: The Enduring Enigma of the Eleusinian Mysteries
Between approximately 1450 BCE and 392 CE, people from across the Mediterranean traveled from Athens to Eleusis(the c...
Latest News
Why Most Drugs Fail, and Why Virtual Tissue Models Beat Virtual Cell Models
Welcome back to Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness!
Ibogaine’s Momentum Is Real. So Is the Safety Gap Nobody’s Solving.
Recent reporting, has documented a string of serious adverse events at overseas psychedelic clinics such as cardiac d...
Was Carlos Castaneda Among the First Psychedelic Grifters?
Author Carlos Castaneda built a fortune on a fabricated Indigenous lineage. A new biography shows how his blueprint s...
University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the ...
Who Gets to Heal?
A donor gift with no diagnosis requirement forced a debate inside Thank You Life. Its executive director asks whether...
Weekly Psychedelic Policy Briefing: August 23, 2026
Oregon's psilocybin program posted its first real-world outcome data this week, just as regulators move on fee increa...